Identification | Back Directory | [Name]
(1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyltriacetate | [CAS]
1298086-18-6 | [Synonyms]
EOS-60361 Ertugliflozin Impuity 4 Ertugliflozin Impurity 4 Ertugliflozin Tetraacetate Tetra Acetyl ertugliflozin (1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octa β-L-Idopyranose, 5-C-[(acetyloxy)methyl]-1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-, 2,3,4-triacetate 5-C-[(Acetyloxy)methyl]-1,6-anhydro-1-C-[4-chloro-3-[(4-ethoxyphenyl)methyl]phenyl]-beta-L-idopyranose 2,3,4-triacetate (1R,2S,3S,4R,5S)-1-(acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyltriacetate | [Molecular Formula]
C30H33ClO11 | [MDL Number]
MFCD32697090 | [MOL File]
1298086-18-6.mol | [Molecular Weight]
605.03 |
Hazard Information | Back Directory | [Uses]
(1R,2S,3S,4R,5S)-1-(Acetoxymethyl)-5-(4-chloro-3-(4-ethoxybenzyl)phenyl)-6,8-dioxabicyclo[3.2.1]octane-2,3,4-triyl Triacetate is an antidiabetic agent and an Ertugliflozin (1210344-57-2) intermediate. |
|
|